Electronic records and signatures
This article was originally published in The Tan Sheet
Executive Summary
Notice of a public meeting on "industry's experience in implementing the technical provisions of regulations on electronic records and electronic signatures" published in the Feb. 22 Federal Register. Cosponsored by FDA and the Parenteral Drug Association, the meeting will be held June 19-20 at the Wyndham Franklin Plaza Hotel in Philadelphia. Those wanting to make presentations must submit abstracts of their talks by March 19 to Angie Fischer, PDA, 7500 Old Georgetown Rd., Suite 620, Bethesda, Md. 20814. For more information, contact Steven Solomon, FDA Office of Enforcement, Office of Regulatory Affairs, at (301)-827-0386. FDA's final reg on electronic records and signatures became effective in August 1997. The meeting will be used to help develop future guidances
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning